Results 151 to 160 of about 700,500 (193)

The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies. [PDF]

Hepatology
Strain R, Edmans M, Montalvo Zurbia-Flores G, Frumento N, Brown A, Hutchings C, Board C, Knight C, Flyak AI, Flyak AI, Bailey J, Lauer G, Cox A, Klenerman P, Barnes E.   +14 more
europepmc   +1 more source

Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response. [PDF]

J Infect Dis, 2022
Varese A, Mazzitelli B, Erra Díaz F, Kjolhede MV, Ojeda D, Vellicce A, Arto P, Cicero C, Pascowsky M, Figueras L, Broese B, Dávila R, Zarlenga R, Rivelli F, Verruno C, Silenzi V, Beltrán I, Gamarnik A, Ceballos A, Zala C, Badolati A, Geffner J.   +21 more
europepmc   +1 more source

Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligand. [PDF]

Vaccine
Hayashi T, Yao S, Sato-Kaneko F, Cozza R, Baba H, Jin J, Mclaughlin I, Gil F, Quiroz PA, Shukla NM, Chan M, Cottam HB, Carson DA.   +12 more
europepmc   +1 more source

Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac^® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. [PDF]

Vaccines (Basel), 2023
Narongkiatikhun P, Noppakun K, Chaiwarith R, Winichakoon P, Vongsanim S, Suteeka Y, Pongsuwan K, Kusirisin P, Wongsarikan N, Fanhchaksai K, Khamwan C, Dankai D, Ophascharoensuk V.   +12 more
europepmc   +1 more source

Heterologous prime-boost with the mRNA-1273 vaccine among CoronaVac-vaccinated healthcare workers in Indonesia. [PDF]

Clin Exp Vaccine Res, 2022
Santi T, Sungono V, Kamarga L, Samakto B, Hidayat F, Hidayat FK, Satolom M, Permana A, Yusuf I, Suriapranata IM, Jo J.   +10 more
europepmc   +1 more source

Long-Term Protective Immune Responses Induced by rBCG-RBD/rRBD Heterologous Prime/Boost Immunization Strategy: Fusion of RBD-Wuhan with LTB Adjuvant Induces Cross-Reactivity with SARS-CoV-2 Variant Omicron. [PDF]

Vaccines (Basel)
Gaboardi GC, Trentini MM, Kanno AI, Moraes L, Januzzi AD, Pereira LR, Dias GBM, Huergo LF, Oliveira SC, Bafica A, Leite LCC.   +10 more
europepmc   +1 more source

Immunogenicity and Safety of Homologous and Heterologous Prime-Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel), 2022
Cheng H, Peng Z, Si S, Alifu X, Zhou H, Chi P, Zhuang Y, Mo M, Yu Y.   +8 more
europepmc   +1 more source

Heterologous prime-boost immunization combining parenteral and mucosal routes with different adjuvants mounts long-lived CD4+ T cell responses in lungs. [PDF]

Front Immunol
Kavishna R, Olafsdottir TA, Brynjólfsson SF, Christensen D, Gustafsson-Hedberg T, Andersen P, Terrinoni M, Holmgren J, Harandi AM.   +8 more
europepmc   +1 more source

Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice. [PDF]

Front Immunol, 2023
Li X, Liu J, Li W, Peng Q, Li M, Ying Z, Zhang Z, Liu X, Wu X, Zhao D, Yang L, Cao S, Huang Y, Shi L, Xu H, Wang Y, Yue G, Suo Y, Nie J, Huang W, Li J, Li Y.   +21 more
europepmc   +1 more source

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice. [PDF]

BMC Vet Res
Li H, Zhang W, Wang W, Qiao Y, Xu M, Liu Z, Gu X, Wu A, Ma Z, Chen C, Zhang W.   +10 more
europepmc   +1 more source